S-metoprolol/Telmisartan

S-美托洛尔/替米沙坦

Report date: 2022/02/11 15:02:35

Base Information

Drug NameS-metoprolol/Telmisartan
Drug Alias NameTelmasartan and S-metoprololS-美托洛尔替米沙坦FDC metoprolol/telmasartan替米沙坦/S-美托洛尔S-metoprolol and Telmisartan +[9] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsBeta adrenergic receptors antagonists
TargetsAngiotensin II Receptor Type 1Beta adrenergic receptors
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2011/01/01
Country/TerritoryIndia
CombinationsYes Metoprolol TartrateTelmisartan
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEmcure Pharma
China Registration ClassN/A

Develop Information

Active CompaniesEmcure Pharma
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09D
Related LinksN/A